The discrepant results were further complicated by another prospective trial in Italy which included patients with cirrhosis and refractory ascites to receive long-term albumin at 20 g twice per week to show a significantly lower 24-month mortality and emergent hospitalizations compared to those who did not receive long-term albumin [58]. Here, ALB is linked to Cirrhosis.